AbbVie (ABBV) stock forecast for 2023

The forecast has been updated: June 29, 2022 7:23


AbbVie stock price online today

Analyst Target Price

163.01

Dividend Date

16.05.2022

Ex Dividend Date

14.04.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell AbbVie stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? AbbVie stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $163.01 target price for AbbVie stock stock.

Today 200 Day Moving Average is the support level (135.95 $).

50 Day Moving Average is the resistance level (150.26 $).




ABBV Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 175.53 165.28 186.63 11.44 %
Mar 169.63 164.48 176.69 6.91 %
Mar 170.31 159.69 181.21 11.88 %
Apr 164.86 160.25 172.78 7.25 %
May 157.08 147.91 163.87 9.74 %
Jun 150.80 145.61 160.33 9.18 %
Jul 148.14 141.51 150.87 6.21 %
Aug 151.34 145.17 154.86 6.25 %
Sep 146.02 137.72 152.21 9.52 %
Oct 147.30 141.88 156.26 9.20 %
Nov 143.65 138.94 148.82 6.64 %
Dec 138.94 131.38 141.27 7.00 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of AbbVie stock.


AbbVie overview

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization

270 615 233 000 $

EBITDA

28 444 000 000

PE Ratio

21.97

PEG Ratio

1.279

Dividend Per Share

5.42

Dividend Yield

0.0408

EPS

6.97

Quarterly Earnings Growth YOY

0.261

Quarterly Revenue Growth YOY

0.041

Trailing PE

21.97

Forward PE

10.24

EV To Revenue

5.63

EV To EBITDA

12.91

52 Week High

174.43

52 Week Low

102.35

50 Day Moving Average

150.26

200 Day Moving Average

135.95

Shares Outstanding

1767110000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

AbbVie stock forecast for this year


AbbVie stock forecast for Jan 2023.
Estimated Average Forecasted AbbVie Price: 175.53. Negative monthly dynamics of the instrument is expected with 11.437% volatility is expected.

Pessimistic forecast: 165.28

Optimistic: 186.63


AbbVie stock forecast for Mar 2023.
Estimated Average Forecasted AbbVie Price: 169.63. Negative monthly dynamics of the instrument is expected with 6.913% volatility is expected.

Pessimistic forecast: 164.48

Optimistic: 176.69


AbbVie stock forecast for Mar 2023.
Estimated Average Forecasted AbbVie Price: 170.31. Positive monthly dynamics of the instrument is expected with 11.879% volatility is expected.

Pessimistic forecast: 159.69

Optimistic: 181.21


AbbVie stock forecast for Apr 2023.
Estimated Average Forecasted AbbVie Price: 164.86. Negative monthly dynamics of the instrument is expected with 7.252% volatility is expected.

Pessimistic forecast: 160.25

Optimistic: 172.78


AbbVie stock forecast for May 2023.
Estimated Average Forecasted AbbVie Price: 157.08. Negative monthly dynamics of the instrument is expected with 9.740% volatility is expected.

Pessimistic forecast: 147.91

Optimistic: 163.87


AbbVie stock forecast for Jun 2023.
Estimated Average Forecasted AbbVie Price: 150.80. Negative monthly dynamics of the instrument is expected with 9.180% volatility is expected.

Pessimistic forecast: 145.61

Optimistic: 160.33


AbbVie stock forecast for Jul 2023.
Estimated Average Forecasted AbbVie Price: 148.14. Negative monthly dynamics of the instrument is expected with 6.206% volatility is expected.

Pessimistic forecast: 141.51

Optimistic: 150.87


AbbVie stock forecast for Aug 2023.
Estimated Average Forecasted AbbVie Price: 151.34. Positive monthly dynamics of the instrument is expected with 6.255% volatility is expected.

Pessimistic forecast: 145.17

Optimistic: 154.86


AbbVie stock forecast for Sep 2023.
Estimated Average Forecasted AbbVie Price: 146.02. Negative monthly dynamics of the instrument is expected with 9.516% volatility is expected.

Pessimistic forecast: 137.72

Optimistic: 152.21


AbbVie stock forecast for Oct 2023.
Estimated Average Forecasted AbbVie Price: 147.30. Positive monthly dynamics of the instrument is expected with 9.200% volatility is expected.

Pessimistic forecast: 141.88

Optimistic: 156.26


AbbVie stock forecast for Nov 2023.
Estimated Average Forecasted AbbVie Price: 143.65. Negative monthly dynamics of the instrument is expected with 6.641% volatility is expected.

Pessimistic forecast: 138.94

Optimistic: 148.82


AbbVie stock forecast for Dec 2023.
Estimated Average Forecasted AbbVie Price: 138.94. Negative monthly dynamics of the instrument is expected with 7.003% volatility is expected.

Pessimistic forecast: 131.38

Optimistic: 141.27



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 108.65 (30.06.2022) -0.41 %
AbbVie Inc.
ABBV 153.16 (30.06.2022) -0.64 %
Aeterna Zentaris Inc.
AEZS 0.2528 (29.06.2022) 40.37 %
Allakos Inc.
ALLK 3.32 (29.06.2022) 2.79 %
Allogene Therapeutics, Inc.
ALLO 11.68 (29.06.2022) 1.74 %
Amgen Inc.
AMGN 243.3 (30.06.2022) -0.87 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 7.58 (29.06.2022) 15.73 %
Aurora Cannabis Inc.
ACB 1.37 (29.06.2022) -8.05 %
Becton Dickinson and Company
BDX 249.34 (29.06.2022) 1.97 %
Biogen Inc.
BIIB 203.94 (30.06.2022) -0.63 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 145.71 (30.06.2022) 0.04 %
BioNTech SE
BNTX 149.1 (30.06.2022) 5.01 %
bluebird bio, Inc.
BLUE 4.58 (29.06.2022) 13.37 %
Boston Scientific Corp.
BSX 37.27 (30.06.2022) -1.40 %
Bristol-Myers Squibb Company
BMY 77 (30.06.2022) -1.64 %
Canopy Growth Corp.
CGC 3.5 (29.06.2022) -3.05 %
Castle Biosciences, Inc.
CSTL 21.95 (30.06.2022) -4.61 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 30.53 (29.06.2022) -2.30 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 5.09 (29.06.2022) -1.74 %
Gilead Sciences, Inc.
GILD 62.48 (29.06.2022) 0.43 %
GlaxoSmithKline plc
GSK 43.77 (29.06.2022) 0.97 %
GoodRx Holdings, Inc.
GDRX 6.3 (29.06.2022) -3.96 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.97 (30.06.2022) 0.11 %
Inovio Pharmaceuticals, Inc.
INO 1.73 (30.06.2022) -3.35 %
Johnson & Johnson
JNJ 177.51 (30.06.2022) 0.29 %
Medtronic plc.
MDT 89.75 (30.06.2022) -0.74 %
Merck & Co., Inc.
MRK 91.17 (30.06.2022) -1.45 %
Moderna, Inc.
MRNA 142.81 (29.06.2022) 0.44 %
Novartis AG
NVS 84.77 (29.06.2022) 0.71 %
Novavax, Inc.
NVAX 51.85 (29.06.2022) 1.55 %
ObsEva SA
OBSV 1.68 (29.06.2022) -2.33 %
OrganiGram Holdings Inc.
OGI 0.9171 (30.06.2022) -5.45 %
Pfizer Inc.
PFE 52.43 (30.06.2022) 2.93 %
Regeneron Pharmaceuticals, Inc.
REGN 591.13 (30.06.2022) -1.09 %
Sanofi
SNY 52.67 (29.06.2022) 1.02 %
Schrodinger, Inc.
SDGR 26.41 (30.06.2022) -4.14 %
Senseonics Holdings, Inc.
SENS 1.01 (29.06.2022) 0.00 %
Sorrento Therapeutics, Inc.
SRNE 1.99 (29.06.2022) 1.53 %
Stryker Corp.
SYK 198.93 (30.06.2022) -0.25 %
Sundial Growers Inc.
SNDL 0.3261 (30.06.2022) -4.43 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.52 (30.06.2022) -5.41 %
Thermo Fisher Scientific Inc.
TMO 543.28 (30.06.2022) 1.37 %
Tilray, Inc.
TLRY 3.12 (30.06.2022) -5.74 %
UnitedHealth Group, Inc.
UNH 513.63 (30.06.2022) -0.40 %
Veeva Systems Inc.
VEEV 198.04 (30.06.2022) -0.85 %
Zomedica Corp.
ZOM 0.2207 (29.06.2022) -12.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 1.14 (30.06.2022) -0.87 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.